SCHEMBL22471065

SCHEMBL22471065

NC(=O)C1(c2ccc(N3CCCCC3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.46
ALDH1A1 P00352 7/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MAPT P10636 4/20 0.46
KDM4E B2RXH2 4/20 0.46
TP53 P04637 3/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
THRB P10828 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18742793 0.95 HSD11B1 (0.48) HSD11B1ALDH1A1NPC1RAB9AMAPT
SCHEMBL5572597 0.84 LMNA (0.55) ALDH1A1MEN1GAAKMT2ANPSR1
SCHEMBL4573204 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10USP2LMNA
SCHEMBL349449 0.83 AKR1C1 (0.52) HSD11B1ALDH1A1NPC1RAB9AMAPT
SCHEMBL38658664 0.76 ALDH1A1 (0.44) HSD11B1ALDH1A1NPC1MAPTKDM4E
SCHEMBL349915 0.75 MAPT (0.46) HSD11B1ALDH1A1NPC1RAB9AMAPT
SCHEMBL20491201 0.74 NPSR1 (0.50) HSD11B1ALDH1A1RAB9AMAPTALOX15
SCHEMBL4767629 0.73 NPC1 (0.61) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL1397421 0.73 NPC1 (0.61) ALDH1A1NPC1RAB9AMAPTKDM4E
SCHEMBL4873981 0.73 NPC1 (0.61) ALDH1A1NPC1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020192302-A1 PYRIMIDINE-CONTAINING TRI-SUBSTITUTED IMIDAZOLE COMPOUND AND APPLICATION THEREOF 广州必贝特医药技术有限公司 2020-10-01 WO disclosed